Publication Name	World Journal of Clinical Cases
Manuscript ID	59705
Country	China

Received	2020-09-23 14:05
Peer-Review Started	2020-09-23 14:06
To Make the First Decision
Return for Revision	2020-12-14 01:37
Revised	2020-12-26 13:23
Second Decision	2021-01-06 10:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-01-06 16:45
Articles in Press	2021-01-06 16:45
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-01-20 23:57
Typeset the Manuscript	2021-02-24 02:26
Publish the Manuscript Online	2021-03-01 03:51

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Metastatic thymic-enteric adenocarcinoma type responding to chemoradiation plus anti-angiogenic therapy: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Man Li, Xiao-Yu Pu, Li-Hua Dong and Peng-Yu Chang
ORCID	Author(s) ORCID Number Man Li http://orcid.org/0000-0002-9876-0125 Xiao-Yu Pu http://orcid.org/0000-0001-9138-1598 Li-Hua Dong http://orcid.org/0000-0002-5148-2949 Peng-Yu Chang http://orcid.org/0000-0001-9047-7942
Funding Agency and Grant Number
Corresponding Author	Li-Hua Dong, PhD, Chief Physician, Department of Radiation Oncology, The First Hospital of Jilin University, No. 71, Xinmin Street, Changchun 130021, Jilin Province, China. drlhdong@163.com
Key Words	Radiotherapy; Chemotherapy; Case report; Thymic adenocarcinoma; Anti-angiogenic therapy; Thymic-enteric adenocarcinoma type
Core Tip	This report introduces the diagnosis and treatment of a metastatic thymic-enteric adenocarcinoma type with positive expression of CDX2 and CK20. For the first time, radiotherapy and chemotherapy combined with anti-angiogenesis therapy were used. The tumor was partially remitted, and there was no sign of recurrence. XELOX (capecitabine plus oxaliplatin) combined with radiotherapy is an alternative treatment of inoperable metastatic thymic-enteric adenocarcinoma.
Publish Date	2021-03-01 03:51
Citation	Li M, Pu X, Dong L, Chang P. Metastatic thymic-enteric adenocarcinoma type responding to chemoradiation plus anti-angiogenic therapy: A case report. World J Clin Cases 2021; 9(7): 1676-1681
URL	https://www.wjgnet.com/2307-8960/full/v9/i7/1676.htm
DOI	https://dx.doi.org/10.12998/wjcc.v9.i7.1676

Full Article (PDF)	WJCC-9-1676.pdf
Full Article (Word)	WJCC-9-1676.docx
Manuscript File	59705_Auto_Edited_WangTQ.docx
Answering Reviewers	59705-Answering reviewers.pdf
Audio Core Tip	59705-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	59705-Conflict-of-interest statement.pdf
Copyright License Agreement	59705-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	59705-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	59705-Language certificate.pdf
Peer-review Report	59705-Peer-review(s).pdf
Scientific Misconduct Check	59705-Bing-Yan JP-1.png
Scientific Misconduct Check	59705-Scientific misconduct check.pdf
Scientific Editor Work List	59705-Scientific editor work list.pdf